AAAAAA
Results:
1-22
|
Results: 22
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Statins in the 21st century: end of the simple story?, EXPERT OP I, 10(9), 2001, pp. 1755-1766
Authors:
Doggrell, SA
Citation: Sa. Doggrell, A daughter of bradykinin that protects against septicaemia, EXPERT OP I, 10(8), 2001, pp. 1567-1569
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Migraine and beyond: cardiovascular therapeutic potential for CGRP modulators, EXPERT OP I, 10(6), 2001, pp. 1131-1138
Authors:
Doggrell, SA
Brown, L
Citation: Sa. Doggrell et L. Brown, The spironolactone renaissance, EXPERT OP I, 10(5), 2001, pp. 943-954
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Carvedilol versus other beta-blockers in heart failure, EXPERT OP I, 10(5), 2001, pp. 971-980
Authors:
Doggrell, SA
Citation: Sa. Doggrell, ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure, EXPERT OP I, 10(5), 2001, pp. 981-983
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Alteplase: descendancy in myocardial infarction, ascendancy in stroke, EXPERT OP I, 10(11), 2001, pp. 2013-2029
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Tedisamil: master switch of nature?, EXPERT OP I, 10(1), 2001, pp. 129-138
Authors:
Doggrell, SA
Mealy, NE
Castaner, J
Citation: Sa. Doggrell et al., CS-747 and R-99224. Platelet antiaggregatory, P2T antagonist., DRUG FUTURE, 26(9), 2001, pp. 835-840
Authors:
Doggrell, SA
Castaner, J
Citation: Sa. Doggrell et J. Castaner, T-1095 - Antidiabetic, sodium-glucose cotransporter inhibitor, DRUG FUTURE, 26(8), 2001, pp. 750-753
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Clinical trials with glycoprotein IIB/IIIA antagonists - No benefit without bleeding?, DRUGS TODAY, 37(8), 2001, pp. 509-531
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Brain natriuretic peptide: Disease marker or more in cardiovascular medicine?, DRUGS TODAY, 37(7), 2001, pp. 463-476
Authors:
Doggrell, SA
Citation: Sa. Doggrell, Is ramipril the pril for diabetes and kidney disease?, DRUGS TODAY, 37(5), 2001, pp. 321-331
Authors:
Doggrell, SA
Chen, YY
Citation: Sa. Doggrell et Yy. Chen, Potency, affinity constants and receptor reserves for noradrenaline and adrenaline on aortae from aged normo- and hypertensive rats, J PHARM PHA, 53(2), 2001, pp. 205-212
Authors:
Doggrell, SA
Brown, L
Citation: Sa. Doggrell et L. Brown, D-Sotalol: death by the SWORD or deserving of further consideration for clinical use?, EXPERT OP I, 9(7), 2000, pp. 1625-1634
Authors:
Nand, V
Doggrell, SA
Citation: V. Nand et Sa. Doggrell, Effects of azimilide on cardiovascular tissues from normo- and hypertensive rats, J CARDIO PH, 36(2), 2000, pp. 209-217
Authors:
Nand, V
Doggrell, SA
Citation: V. Nand et Sa. Doggrell, Effects of clofilium on cardiovascular tissues from normo- and hypertensive rats, J AUT PHARM, 20(3), 2000, pp. 185-192
Authors:
Yuill, KH
Convery, MK
Dooley, PC
Doggrell, SA
Hancox, JC
Citation: Kh. Yuill et al., Effects of BDF 9198 on action potentials and ionic currents from guinea-pig isolated ventricular myocytes, BR J PHARM, 130(8), 2000, pp. 1753-1766
Authors:
Doggrell, SA
Nand, V
Henderson, CJ
Citation: Sa. Doggrell et al., The effects of lignocaine and tetrodotoxin on the action potentials and contractions of left ventricles from normo- and hypertensive rats, GEN PHARM, 32(4), 1999, pp. 429-437
Authors:
Nand, V
Doggrell, SA
Citation: V. Nand et Sa. Doggrell, Effects of BDF 9148 on the action potentials and contractions of left ventricles from normo- and hypertensive rats, CLIN EXP PH, 26(3), 1999, pp. 212-219
Authors:
Doggrell, SA
Wanstall, JC
Gambino, A
Citation: Sa. Doggrell et al., Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats, N-S ARCH PH, 360(3), 1999, pp. 317-323
Authors:
Nand, V
Doggrell, SA
Citation: V. Nand et Sa. Doggrell, Effects of tetraethylammonium, 4-aminopyridine and bretylium on cardiovascular tissues from normo- and hypertensive rats, J PHARM PHA, 51(5), 1999, pp. 631-640
Risultati:
1-22
|